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<LETTERS TO EDITOR> 
Chimpanzees in Japan Need 
Help. 
Tetsuro Matsuzawa 
Primate Research Institute,.Kyoto University 
e-mail: matsuzaw@prikyoto-u.ac.jp 
For over a decade now, there have been 
no invasive studies of chimpanzees in Japan. 
However, it has come to our attention that a 
medical company has recently set out to subject 
the chimpanzees in its care to invasive studies of 
the hepatitis c virus as well as certain types of 
gene therapy. The number of biomedical subjects 
in invasive studies will increase in the nearest 
future unless we attempt and succeed in finding 
an acceptable solution. As a first step, I asked 
Japanese· scientists to· organize SAGA (Support 
for African/Asian Great Apes) symposium in 
November 1998 that have decided to put forward 
an agenda . calling for the cessation of invasive 
studies in captive chimpanzees. 
Japan is at present home to 388 
chimpanzees, 37 gorillas, and 57 orangutans. 
There are currently no bonobos in the country. 
All gorillas and orangutans are housed in zoos. 
Of the 388 chimpanzees, a group of 11 is kept at 
the Primate Research Institute of Kyoto 
University, participating in noninvasive studies 
such as cognitive and behavioral re~earch. A 
further 237 chimpanzees are distributed over 50 
zoos, and 4 belong to circuses or commercial 
productions. The remaining 136 chimpanzees, 
one third of the total population in Japan, are 
kept in the facilities of three medical companies. 
They have 107, 16, and · 13 chimpanzees, 
respectively. All of these are either chimpanzees 
who had been used in hepatitis B research, or 
the descendants of the latter. 
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A total of 151 chinl.panzees served as 
hepatitis B research subjects during the period 
between 1975 and 1986 in Japan. Of this group, 
83 chimpanzees had been imported directly from 
Sierra Leone, until Japan ratified CITES in 
1980. ·Biomedical researchers were supported 
financially by the Ministry of Health and 
Welfare, and played the key part in conducting 
invasive research. A number of chimpanzees 
were kept in the . scientists' associated 
universitie~, while some others were housed in· 
the three medical companies. Hepatitis B 
research using chimpanzees ended in Japan in 
1987, thanks to the development of~ vaccine for 
the hepatitis B virus. By that time, 45 
chimpanzees participating in the relevant 
studies had already died. Researchers retired 
and sent the surviving chimpanzees on to the 
medical companies. The chimpanzees received in 
this way were subsequently bred in a medical 
company and their numbers increased: 
A few researchers continue to nurture 
an interest in hepatitis C research using 
chimpanzees. They recently launched an . 
experiment of the infectious hepatitis C virus in 
healthy chimpanzees in collaboration with the 
medical . company. O,ther researchers plan ·to 
begin gene therapy studies fo~ diseases such as 
cancer and AIDS in chimpanzees. The 
experiments would entail safety checks of the 
vectors that carry specific genes into target 
organs. The company, which has been 
encouraged by the biomedical use of 
chimpanzees in the USA, appears in its policies 
to strongly favour the biomedical/invasive use of 
its 107 chimpanzees. Ministry of· Education, 
Science, and · Culture has never financially 
supported such a kind of invasive · study in 
chimpanzees in Japan, but the Ministry of 
Health and Welfare has. 
The researchers of chimpanzees are 
aware of how small the distances are that 
separate chimpanzees and other great apes from 
humans. All the great ape species are listed as 
"endangered" in CITES. Their numbers in the 
wild are decreasing, and captive populations 
remain small. Individuals survive 40 to 50 years, 
in some cases even longer. These characteristics 
are' not congruent with the standards for so-
called experimental animals. We believe that 
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there need to be serious constraints on the 
biomedical use of chimpanzees and other great 
apes. SAGA symposium 1998 proposed the 
following agenda to promote our scientific 
understanding of all great apes. The agenda is 
approved by the following primatologists who 
participated in the SAGA symposium: Toshisada 
Nishida, Yuk.imaru Sugiyama, Tasuku Kimura, 
Osamu Takenaka, Shozo K~jima, Takayoshi 
Kano, Juichi Yamagiwa, Juh'ichiro Itani, Masao 
Kawai, Jane Goodall, and Jan van Hooff. 
First, we shall undertake action for the 
conservation of the great apes and their natural 
habitat. Second, we shall endeavor to enhan<;e 
the quality of life of the great apes ·in captivity. 
Third, we shall not use the great apes as 
subjects in invasive studies, but promote our 
scientific understanding through non-invasive 
techniques. 
For our purposes, the word "invasive" 
refers to the treatment that causes· irreversible 
deficits of normal function. In short, illegal or 
non-ethical treatment prohibited in the case of 
human subjects is to be likewise prohibited in 
the great apes. 
Based on this SAGA agenda, we hope to 
halt current trends of invasive biomedical use of 
chimpanzees in Japan. We will then devise 
further plans for the scientific use of the 136 
chimpanzees currently in the care of the medical 
companies from a broader perspective. 
Researchers, medical companies, Ministries, and 
the people who are working for the great apes 
need to cooperate together to develop a suitable 
solution, as these chimpanzees represent unique 
genetic resources existing in Japan. The 
founding of a national institute for the scientific 
and . noninvasive use of captive chimpanzees 
should be seen as a realistic goal.-
I hope that primatologists all over the 
world will demonstrate their approval and 
support of SAGA attempt toward a better life for 
chimpanzees ~d other great apes in the coming 
century. Further correspondence should be the 
following e-mail address: 
saga@smtp.pri.kyoto-u.ac.jp 
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<LETTERS TO EDITOR> 
The Hominid Rights. 
Rowan Taylor (Information Officer) 
Barbara Leonard (Secretary) 
Great Ape Project NZ h1c 
25 Ramahana Road 
Christchurch ~ New Zealand 
Email· leonard@tui.lihcoln.ac.nz 
Fax: +64 3 332 5081 
We are writing on behalf of the Great 
Ape Project New Zealand Inc. to invite your 
support for a scientists' initiative to elevate the 
legal status of nonhuman hominids. You may 
already have heard or read about in the media, on 
the Internet, or in Science or New Scientist. 
THE HOMINID RIGHTS amendment 
was proposed by a coalition ·of scientists, 
philosophers and lawyers in submissions on New 
Zealand's new Animal Welfare Bill. The 
submitters have called for an extra section to be , 
inserted in the new Bill giving chimpanzees, 
bonobos, gorillas and orang-utans fundamental 
legal rights similar to those held by young 
children and handicapped adults. 
If successful, the proposal could 
revolutionise the way great apes are seen and 
treated. The three proposed rights are: 
(1) the right to not be deprived of life; 
(2) the right to not be tortured or treated in 
cruel or degrading ways; 
and 
(3) the right to not be used in experiments that, 
in a court's opinion, would not be in their best 
interests. 
ARIGHT TO LIBERTY is not sought in 
the proposal because, outside their natural 
environment, non-human hominids, like small 
children, lack the rationality to exercise freedom 
safely and responsibly. Liberty is· thus a relative 
term and difficult to apply without suitably 
designed sanctuaries, which· New Zealand is not 
currently in a position to-provide. 
EXPERIMENTATION on _hominids is 
. not barred by the proposal, provided it meets the 
